Similar Items: Aspartame drives the continuous progression from MASLD to HCC
- A NEK2/ZWINT–NDC80 regulatory axis drives bladder cancer progression and chemoresistance
- Construction of an eight-disulfidptosis-related long non-coding RNA prognostic signature and mechanistic investigation of key molecule MKLN1-AS driving hepatocellular carcinoma progression via the miR-139-5p/LRPPRC axis
- Platelet–Prostate cancer crosstalk driving disparities and therapeutic vulnerabilities
- Emerging roles of LINC01614 in cancer progression and therapy response
- Metabolic reprogramming regulates macrophage polarization to impact ovarian cancer progression
- Research progress and challenges of multimodal deep learning models for prognosis of gastric cancer